Eric Dane

Eric Dane is a Principal Scientist in the Advanced Drug Delivery Group at AstraZeneca, specializing in the formulation and delivery of next-generation RNA vaccines. They previously held positions at CSL Seqirus and served as a Research Scientist at the Koch Institute for Integrative Cancer Research at MIT, where their research focused on improving systemic delivery for antitumor immunity. Eric completed their PhD in Chemistry at the Massachusetts Institute of Technology, where they designed and synthesized novel organic materials for varied applications. As a postdoc at Boston University, they synthesized and characterized organic macromolecules for biomedical applications.